Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2026-01-04 @ 4:22 PM
Study NCT ID:
NCT03114657
Status:
TERMINATED
Last Update Posted:
2020-07-16
First Post:
2017-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-28
First Submit QC Date:
None
Study First Post Date:
2017-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-26
Results First Submit QC Date:
None
Results First Post Date:
2020-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-01
Last Update Post Date:
2020-07-16
Last Update Post Date Type:
ACTUAL